discoveryliter
act
uncoveringimpli
new
fundament
observ
chang
way
view
respond
world
imag
eureka
found
moment
rare
scienc
given
physiqu
mani
scientist
may
good
thing
legend
archimed
discov
bath
volum
object
could
calcul
find
volum
water
displac
leap
bathtub
ran
nake
street
syracus
proclaim
discoveri
rate
discoveri
new
microb
new
associ
microb
health
diseas
acceler
past
two
decad
mani
factor
implic
new
pathogen
truli
emerg
global
travel
trade
chang
demograph
land
use
suscept
opportunist
organ
associ
immunosuppress
climat
chang
new
molecular
technolog
masstag
pcr
microbi
microarray
unbias
high
throughput
sequenc
ht
enabl
effici
microbi
surveil
discoveri
databas
need
recogn
sequenc
host
microbi
improv
dramat
sampl
collect
becom
sophist
comprehens
last
least
model
pathogenesi
embrac
increasingli
complex
mechan
consid
hostmicrobetim
interact
acut
chronic
diseas
find
organ
one
step
establish
causal
relationship
understand
caus
diseas
mani
wrestl
challeng
codifi
process
prove
causat
base
germ
theori
diseas
pasteur
koch
loeffler
propos
criteria
defin
caus
relationship
agent
diseas
agent
present
everi
case
diseas
specif
diseas
propag
cultur
inocul
host
caus
diseas
known
koch
postul
criteria
modifi
river
virus
frederick
relman
reflect
introduct
molecular
method
although
fulfil
koch
postul
remain
persuas
evid
causat
problem
hold
standard
overlap
sign
symptom
due
infect
differ
agent
common
result
infect
may
vari
genet
background
age
nutrit
previou
exposur
similar
agent
mani
agent
cultur
furthermor
may
anim
model
prove
causat
particularli
challeng
agent
remot
effect
requir
cofactor
express
mani
acut
infecti
diseas
respons
agent
readili
implic
replic
high
level
affect
tissu
time
diseas
manifest
morpholog
chang
consist
infect
evid
agent
readili
identifi
classic
molecular
method
evid
adapt
immun
respons
howev
implic
difficult
classic
hallmark
infect
absent
mechan
pathogenesi
indirect
subtl
one
may
resort
statist
assess
strength
epidemiolog
associ
base
presenc
agent
footprint
nucleic
acid
antigen
prefer
immun
respons
biolog
plausibl
indic
analog
diseas
organ
linkag
persuas
implic
agent
easiest
present
high
concentr
site
diseas
diseas
manifest
exampl
includ
poliomyel
death
infect
motor
neuron
result
paralysi
infecti
diarrhea
caus
agent
bacterium
viru
parasit
found
gastrointestin
tract
complex
exampl
intox
occur
botul
tetanu
replic
subcutan
tissu
gastrointestin
tract
result
releas
toxin
remot
effect
nervou
system
pathogenesi
may
immunemedi
hepatocellular
carcinoma
due
persist
hepat
b
hepat
c
infect
infect
also
impair
immun
function
open
imag
author
engag
process
scientif
discoveri
editor
mariann
manchest
scripp
research
institut
unit
state
america
door
opportunist
pathogen
observ
date
back
earli
von
pirquet
note
loss
skin
reactiv
tuberculin
associ
measl
infect
howev
best
known
context
hivaid
effect
infect
may
depend
age
matur
statu
host
individu
either
extrem
life
increas
risk
morbid
mortal
infect
organogenesi
may
differ
consequ
time
birth
defect
accompani
prenat
infect
toxoplasma
rubella
cytomegalo
herpesvirus
persist
viral
infect
subtl
effect
cellular
physiolog
result
alter
express
neurotransmitt
hormon
profound
effect
includ
cognit
impair
hypothyroid
diabet
mellitu
infect
break
toler
self
result
autoimmun
diseas
autoimmun
may
restrict
tissu
agent
replic
presum
host
antigen
tissu
present
new
context
howev
crossreact
immun
respons
may
impact
distanc
molecular
mimicri
streptococc
infect
pharynx
skin
result
immun
heart
brain
caus
valvular
diseas
chorea
respect
constel
direct
indirect
pathway
diseas
short
long
term
pose
challeng
pathogen
discoveri
although
review
pathogen
surveil
discoveri
typic
focu
latest
molecular
technolog
import
emphas
pivot
role
clinic
acumen
patholog
serolog
classic
cultur
techniqu
clinician
epidemiologist
prime
mover
pathogen
discoveri
recogn
appear
new
syndrom
collect
materi
investig
persuad
colleagu
take
search
anatom
patholog
instrument
direct
molecular
work
discoveri
nipah
viru
west
nile
viru
facilit
demonstr
henipaviru
flaviviru
protein
tissu
allow
focus
consensu
pcr
analys
classic
virolog
method
tissu
cultur
serolog
prove
pivot
sar
outbreak
propag
viru
tissu
cultur
enabl
rapid
character
consensu
random
pcr
clone
microarray
electron
microscopi
advent
method
clone
nucleic
acid
microbi
pathogen
directli
clinic
specimen
usher
new
era
pathogen
discoveri
past
two
decad
subtract
clone
express
clone
consensu
pcr
high
throughput
pyrosequenc
result
identif
novel
agent
associ
acut
chronic
diseas
includ
borna
diseas
viru
hepat
c
viru
sin
nombr
viru
bartonella
hensela
tropheryma
whippelii
nipah
viru
sar
coronaviru
israel
acut
paralysi
viru
familiar
molecular
assay
clinic
microbiolog
singleplex
pcr
assay
design
detect
quantit
burden
individu
candid
organ
revolution
blood
bank
drug
manag
hiv
contain
outbreak
infecti
diseas
degener
primer
employ
singleplex
pcr
assay
reduc
stringenc
facilit
detect
relat
unknown
organ
howev
clinic
manifest
typic
pathognomon
infect
specif
pathogen
thu
unless
investig
clue
narrow
search
cumbersom
strategi
even
sampl
resourc
time
suffici
invest
mani
singleplex
assay
differ
agent
contrast
multiplex
assay
simultan
entertain
mani
hypothes
number
candid
consid
rang
less
ten
multiplex
pcr
thousand
microarray
entir
tree
life
ht
cost
eas
use
improv
nonetheless
multiplex
pcr
assay
wide
use
present
microarray
ht
mani
genet
target
compet
assay
compon
eg
nucleotid
polymeras
dye
instanc
differ
effici
abrog
quantit
reduc
sensit
cost
pathogen
discoveri
contain
stage
invest
epidemiolog
serolog
patholog
suggest
one
candid
singleplex
pcr
ideal
clue
pertain
singleplex
assay
fail
syndrom
multiplex
pcr
assay
allow
rapid
examin
candid
modest
increas
time
expens
microarray
indic
multiplex
pcr
fail
method
requir
agent
relat
one
alreadi
known
agent
novel
suffici
distant
sequenc
confound
hybrid
may
requir
subtract
clone
ht
irrespect
rout
result
identif
candid
subsequ
step
includ
quantit
pathogen
burden
affect
host
control
detail
character
pathogen
featur
may
contribut
virul
provid
clue
proven
serolog
index
acut
infect
tool
examin
preval
infect
time
geographi
nucleic
acid
platform
continu
evolv
enabl
faster
sensit
less
expens
method
direct
microbi
detect
improv
develop
platform
includ
microfluid
sampl
process
direct
measur
conduct
chang
hybrid
proteom
host
respons
profil
may
yet
yield
diagnost
biomark
advanc
technolog
fail
sampl
degrad
data
uninterpret
without
accur
inform
clinic
cours
sampl
proven
thu
emphasi
place
engag
clinician
equal
partner
chronic
diseas
earli
exposur
andor
genet
suscept
may
influenc
pathogenesi
substant
advanc
link
microb
diseas
may
come
invest
prospect
serial
sampl
collect
model
wherein
diseas
reflect
intersect
gene
environ
tempor
context
